Literature DB >> 1402645

Treatment of giant cell arteritis with cyclophosphamide pulses.

S de Vita, A Tavoni, G Jeracitano, G Gemignani, M P Dolcher, S Bombardieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1402645

Source DB:  PubMed          Journal:  J Intern Med        ISSN： 0954-6820            Impact factor:   8.989


× No keyword cloud information.
  8 in total

Review 1.  Polymyalgia rheumatica/temporal arteritis: recent advances.

Authors:  Maria-Louise Barilla-LaBarca; Deborah J Lenschow; Richard D Brasington
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

Review 2.  [Current therapeutic options for giant cell arteritis].

Authors:  E Wipfler-Freissmuth; J Loock; F Moosig; C Dejaco; C Duftner; M Schirmer
Journal:  Z Rheumatol       Date:  2009-03       Impact factor: 1.372

Review 3.  The treatment of giant cell arteritis.

Authors:  J Alexander Fraser; Cornelia M Weyand; Nancy J Newman; Valérie Biousse
Journal:  Rev Neurol Dis       Date:  2008

4.  An unusual cause of bilateral ophthalmoplegia.

Authors:  Katharine L Warburton; Elizabeth Austen; Andrew Gough; Gunther E Wihl
Journal:  BMJ Case Rep       Date:  2010-12-20

Review 5.  Giant cell arteritis. Epidemiology and treatment.

Authors:  E Nordborg; R Andersson; B A Bengtsson
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

6.  Headache Caused by Giant Cell Arteritis.

Authors:  Thomas N Ward; Morris Levin; Robert L Wong
Journal:  Curr Treat Options Neurol       Date:  2004-11       Impact factor: 3.598

7.  Design of the tocilizumab in giant cell arteritis trial.

Authors:  Sebastian H Unizony; Bhaskar Dasgupta; Elena Fisheleva; Lucy Rowell; Georg Schett; Robert Spiera; Jochen Zwerina; Olivier Harari; John H Stone
Journal:  Int J Rheumatol       Date:  2013-04-07

Review 8.  Horton's disease: past and present.

Authors:  Morris Levin; Thomas N Ward
Journal:  Curr Pain Headache Rep       Date:  2005-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.